Estrophilin immunoreactivity versus estrogen receptor binding activity in meningiomas: evidence for multiple estrogen binding sites.

The existence of estrogen receptors in human meningiomas has long been a controversial issue. This may be explained, in part, by apparent heterogeneity of estrogen binding sites in meningioma tissue. In this study, estrogen receptors were determined in 58 meningiomas with an enzyme immunoassay using monoclonal antibodies against human estrogen receptor protein (estrophilin) and with a sensitive radioligand binding assay using 125I-labeled estradiol (125I-estradiol) as radioligand. Low levels of estrophilin immunoreactivity were found in tumors from 62% of patients, whereas radioligand binding activity was demonstrated in about 46% of the meningiomas examined. In eight (14%) tissue samples multiple binding sites for estradiol were observed. The immunoreactive binding sites correspond to the classical, high affinity estrogen receptors: the Kd for 125I-estradiol binding to the receptor was approximately 0.2 nM and the binding was specific for estrogens. The second, low affinity class of binding sites considerably influenced measurement of the classical receptor even at low ligand concentrations. The epidemiological and clinical data from patients with meningiomas, and the existence of specific estrogen receptors confirmed by immunochemical detection, may be important factors in a theory of oncogenesis.
AuthorsK P Lesch, W Schott, S Gross
JournalSurgical neurology (Surg Neurol) Vol. 28 Issue 3 Pg. 181-8 (Sep 1987) ISSN: 0090-3019 [Print] UNITED STATES
PMID3306997 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Carrier Proteins
  • Iodine Radioisotopes
  • Receptors, Estrogen
  • estrophilin
  • Estradiol
  • Antibodies, Monoclonal
  • Binding Sites
  • Carrier Proteins (metabolism)
  • Estradiol (metabolism)
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Iodine Radioisotopes
  • Male
  • Meningeal Neoplasms (metabolism)
  • Meningioma (metabolism)
  • Middle Aged
  • Radioligand Assay
  • Receptors, Estrogen (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: